120 related articles for article (PubMed ID: 19352303)
1. Genetic variations in UGT1A1 and UGT2B7 and endometrial cancer risk.
McGrath M; Lepine J; Lee IM; Villeneuve L; Buring J; Guillemette C; De Vivo I
Pharmacogenet Genomics; 2009 Mar; 19(3):239-43. PubMed ID: 19352303
[TBL] [Abstract][Full Text] [Related]
2. The functional UGT1A1 promoter polymorphism decreases endometrial cancer risk.
Duguay Y; McGrath M; Lépine J; Gagné JF; Hankinson SE; Colditz GA; Hunter DJ; Plante M; Têtu B; Bélanger A; Guillemette C; De Vivo I
Cancer Res; 2004 Feb; 64(3):1202-7. PubMed ID: 14871858
[TBL] [Abstract][Full Text] [Related]
3. The function of uterine UDP-glucuronosyltransferase 1A8 (UGT1A8) and UDP-glucuronosyltransferase 2B7 (UGT2B7) is involved in endometrial cancer based on estrogen metabolism regulation.
Zhao F; Wang X; Wang Y; Zhang J; Lai R; Zhang B; Zhou X
Hormones (Athens); 2020 Sep; 19(3):403-412. PubMed ID: 32592099
[TBL] [Abstract][Full Text] [Related]
4. UGT1A1 genetic polymorphisms, endogenous estrogen exposure, soy food intake, and endometrial cancer risk.
Deming SL; Zheng W; Xu WH; Cai Q; Ruan Z; Xiang YB; Shu XO
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):563-70. PubMed ID: 18349273
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in CYP11A1 and StAR in relation to endometrial cancer risk.
Terry K; McGrath M; Lee IM; Buring J; De Vivo I
Gynecol Oncol; 2010 May; 117(2):255-9. PubMed ID: 20199803
[TBL] [Abstract][Full Text] [Related]
6. Novel breast cancer risk alleles and endometrial cancer risk.
McGrath M; Lee IM; Buring J; Hunter DJ; De Vivo I
Int J Cancer; 2008 Dec; 123(12):2961-4. PubMed ID: 18785201
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in UDP glucuronosyltransferase genes: functional consequences and clinical relevance.
Mackenzie PI; Miners JO; McKinnon RA
Clin Chem Lab Med; 2000 Sep; 38(9):889-92. PubMed ID: 11097345
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in genes hydroxysteroid-dehydrogenase-17b type 2 and type 4 and endometrial cancer risk.
Karageorgi S; McGrath M; Lee IM; Buring J; Kraft P; De Vivo I
Gynecol Oncol; 2011 Apr; 121(1):54-8. PubMed ID: 21129770
[TBL] [Abstract][Full Text] [Related]
9. Contribution of the different UDP-glucuronosyltransferase (UGT) isoforms to buprenorphine and norbuprenorphine metabolism and relationship with the main UGT polymorphisms in a bank of human liver microsomes.
Rouguieg K; Picard N; Sauvage FL; Gaulier JM; Marquet P
Drug Metab Dispos; 2010 Jan; 38(1):40-5. PubMed ID: 19841060
[TBL] [Abstract][Full Text] [Related]
10. HSD17B1 gene polymorphisms and risk of endometrial and breast cancer.
Setiawan VW; Hankinson SE; Colditz GA; Hunter DJ; De Vivo I
Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):213-9. PubMed ID: 14973105
[TBL] [Abstract][Full Text] [Related]
11. Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy.
Holthe M; Klepstad P; Zahlsen K; Borchgrevink PC; Hagen L; Dale O; Kaasa S; Krokan HE; Skorpen F
Eur J Clin Pharmacol; 2002 Aug; 58(5):353-6. PubMed ID: 12185559
[TBL] [Abstract][Full Text] [Related]
12. CYP19 (aromatase) haplotypes and endometrial cancer risk.
Paynter RA; Hankinson SE; Colditz GA; Kraft P; Hunter DJ; De Vivo I
Int J Cancer; 2005 Aug; 116(2):267-74. PubMed ID: 15800924
[TBL] [Abstract][Full Text] [Related]
13. Equine uridine diphospho-glucuronosyltransferase 1A1, 2A1, 2B4, 2B31: cDNA cloning, expression and initial characterization of morphine metabolism.
Hamamoto-Hardman BD; Baden RW; McKemie DS; Knych HK
Vet Anaesth Analg; 2020 Nov; 47(6):763-772. PubMed ID: 32933848
[TBL] [Abstract][Full Text] [Related]
14. Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk.
Rebbeck TR; Troxel AB; Wang Y; Walker AH; Panossian S; Gallagher S; Shatalova EG; Blanchard R; Bunin G; DeMichele A; Rubin SC; Baumgarten M; Berlin M; Schinnar R; Berlin JA; Strom BL
J Natl Cancer Inst; 2006 Sep; 98(18):1311-20. PubMed ID: 16985250
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility.
McGrath M; Hankinson SE; Arbeitman L; Colditz GA; Hunter DJ; De Vivo I
Carcinogenesis; 2004 Apr; 25(4):559-65. PubMed ID: 14656940
[TBL] [Abstract][Full Text] [Related]
16. Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels.
Guillemette C; De Vivo I; Hankinson SE; Haiman CA; Spiegelman D; Housman DE; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):711-4. PubMed ID: 11401924
[TBL] [Abstract][Full Text] [Related]
17. Glucuronidation of catechol estrogens by expressed human UDP-glucuronosyltransferases (UGTs) 1A1, 1A3, and 2B7.
Cheng Z; Rios GR; King CD; Coffman BL; Green MD; Mojarrabi B; Mackenzie PI; Tephly TR
Toxicol Sci; 1998 Sep; 45(1):52-7. PubMed ID: 9848110
[TBL] [Abstract][Full Text] [Related]
18. Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control study.
Falkowski S; Woillard JB; Postil D; Tubiana-Mathieu N; Terrebonne E; Pariente A; Smith D; Guimbaud R; Thalamas C; Rouguieg-Malki K; Marquet P; Picard N
BMC Cancer; 2017 Dec; 17(1):901. PubMed ID: 29282011
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive variant screening of the UGT gene family.
Kim JY; Cheong HS; Park BL; Kim LH; Namgoong S; Kim JO; Kim HD; Kim YH; Chung MW; Han SY; Shin HD
Yonsei Med J; 2014 Jan; 55(1):232-9. PubMed ID: 24339312
[TBL] [Abstract][Full Text] [Related]
20. UGT1A1, UGT1A6 and UGT1A7 genetic analysis: repercussion for irinotecan pharmacogenetics in the São Miguel Island Population (Azores, Portugal).
Pacheco PR; Brilhante MJ; Ballart C; Sigalat F; Polena H; Cabral R; Branco CC; Mota-Vieira L
Mol Diagn Ther; 2009; 13(4):261-8. PubMed ID: 19712005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
